Cynthia Chestek, Ph.D., Paul Cederna, MD
Second year of funding – 2014 funding: $102,798; funding to date: $222,588
Every day in the US, 507 people lose a limb; while, 1000 children per year are born with limb defects. The use of prosthetic devices may determine whether persons with amputations return to work. Advanced prosthetic Continue Reading »
Nicholas Langhals, Ph.D., Paul Cederna, MD
There are 1.7 million people living with limb loss in the U.S., increasing by 185,000 each year. All of these amputees will develop neuromas, or large, tangled bundles of nerve and scar tissue, due to the untreated nerve division and/or trauma at the amputation site. Of patients with neuromas, Continue Reading »
Sunitha Nagrath, Ph.D. and Kyle Cuneo, MD
$149,059
CTCs are cells that have detached from a primary tumor and enter the bloodstream with the potential to establish secondary metastatic tumors all over the body. CTCs are prognostic indicators and carry with them information about genetic mutations of the primary tumor and its sensitivity to drugs. Continue Reading »
Douglas Noll, Ph.D., Bradley Foerster, MD
$102,710
Susan Shore, Ph.D., Gregory Basura, MD
Second year of funding – 2014 funding: $140,327; funding to date $210,825